NASDAQ
Kalaris Therapeutics Inc (KLRS) has a free cash flow growth of -43.03% as of Friday, May 29, 2026. This represents a 194.40% decrease compared to its 12-month average of -14.61%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.